Philip Halverson
Clinical Research Institute(US)Asthma and Allergy Specialists(US)
Publications by Year
Research Areas
Asthma and respiratory diseases, Allergic Rhinitis and Sensitization, Inhalation and Respiratory Drug Delivery, Chronic Obstructive Pulmonary Disease (COPD) Research, Migraine and Headache Studies
Most-Cited Works
- → Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine(2020)98 cited
- → Serious adverse reactions to protamine sulfate: Are alternatives needed?(1985)71 cited
- → Effectiveness of Azelastine Nasal Solution in Seasonal Allergic Rhinitis(1994)47 cited
- Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.(1994)
- → A Novel Breath Actuated Device (Autohaler™) Consistently Actuates During the Early Phase of Inspiration(1995)15 cited
- C1 INH deficiency and angioedema: a spectrum of disease. Part one.(1984)
- → 613 Occupational asthma in egg crackers is associated with extraordinarily high airborne egg allergen concentration(1988)5 cited
- → The Effectiveness of Oral Azelastine in the Management of Perennial Allergic Rhinitis(1994)3 cited
- → Oral Rimegepant 75 mg Is Well-tolerated When Used Concomitantly with Injectable Anti-CGRP Monoclonal Antibodies: Results From a Multicenter, Long-term, Open-label Safety Study (4553)(2020)2 cited
- → The evaluation of the correct use and ease‐of use of the ELLIPTA DPI in children with asthma(2020)1 cited